Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies
Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies
复制标题
DOI:
10.1001/jamaneurol.2020.0673
复制
发表时间:
2020-07-01
期刊:
影响因子:
29
通讯作者:
Nishino, Ichizo
中科院分区:
文献类型:
--
作者:
Inoue, Michio;Tanboon, Jantima;Nishino, Ichizo
This study confirms the existence of dermatomyositis sine dermatitis, determines its prevalence, and characterizes the serologic features of dermatomyositis sine dermatitis.Importance Reports on dermatomyositis (DM) sine dermatitis (DMSD) are scarce, and the concept of the disease has not been widely accepted. Objective To confirm the existence of DMSD, determine its prevalence, and characterize its serologic features. Design, Setting, and Participants This is a cohort study that reviewed clinical information, laboratory data, and muscle pathology slides from January 2009 to August 2019. We further assessed the follow-up data of 14 patients with DMSD. The median (interquartile range) follow-up period was 34 (16-64) months. Muscle biopsy samples, along with clinical information and laboratory data, were sent to a referral center for muscle diseases in Japan for diagnosis. Of patients whose myopathologic diagnosis was made at the National Center of Neurology and Psychiatry between January 2009 and August 2019, 199 patients were eligible for inclusion. These patients underwent full investigation for DM-specific autoantibodies (against transcriptional intermediary factor gamma, Mi-2, melanoma differentiation-associated gene 5, nuclear matrix protein 2 [NXP-2], and small ubiquitin-like modifier activating enzyme ); however, 17 patients were excluded because their muscle fibers did not express myxovirus resistance protein A, a sensitive and specific marker of DM muscle pathology. Main Outcomes and Measures Diagnosis of DMSD was based on the absence of a skin rash at the time of muscle biopsy. Results Of the 182 patients, 93 were women (51%) and 46 were children (25%) (